168 related articles for article (PubMed ID: 15354061)
1. Beryllium medical surveillance at a former nuclear weapons facility during cleanup operations.
Sackett HM; Maier LA; Silveira LJ; Mroz MM; Ogden LG; Murphy JR; Newman LS
J Occup Environ Med; 2004 Sep; 46(9):953-61. PubMed ID: 15354061
[TBL] [Abstract][Full Text] [Related]
2. Beryllium sensitization and chronic beryllium disease at a former nuclear weapons facility.
Stange AW; Hilmas DE; Furman FJ; Gatliffe TR
Appl Occup Environ Hyg; 2001 Mar; 16(3):405-17. PubMed ID: 11297055
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of beryllium sensitization and disease in nuclear workers.
Kreiss K; Mroz MM; Zhen B; Martyny JW; Newman LS
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):985-91. PubMed ID: 8214955
[TBL] [Abstract][Full Text] [Related]
4. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
[TBL] [Abstract][Full Text] [Related]
5. Sensitization and chronic beryllium disease among workers in copper-beryllium distribution centers.
Stanton ML; Henneberger PK; Kent MS; Deubner DC; Kreiss K; Schuler CR
J Occup Environ Med; 2006 Feb; 48(2):204-11. PubMed ID: 16474270
[TBL] [Abstract][Full Text] [Related]
6. Beryllium disease among construction trade workers at Department of Energy nuclear sites.
Welch LS; Ringen K; Dement J; Bingham E; Quinn P; Shorter J; Fisher M
Am J Ind Med; 2013 Oct; 56(10):1125-36. PubMed ID: 23794247
[TBL] [Abstract][Full Text] [Related]
7. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant.
Henneberger PK; Cumro D; Deubner DD; Kent MS; McCawley M; Kreiss K
Int Arch Occup Environ Health; 2001 Apr; 74(3):167-76. PubMed ID: 11355290
[TBL] [Abstract][Full Text] [Related]
8. Risk of beryllium sensitization in a low-exposed former nuclear weapons cohort from the Cold War era.
Mikulski MA; Leonard SA; Sanderson WT; Hartley PG; Sprince NL; Fuortes LJ
Am J Ind Med; 2011 Mar; 54(3):194-204. PubMed ID: 21298695
[TBL] [Abstract][Full Text] [Related]
9. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
[TBL] [Abstract][Full Text] [Related]
10. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites.
Welch L; Ringen K; Bingham E; Dement J; Takaro T; McGowan W; Chen A; Quinn P
Am J Ind Med; 2004 Sep; 46(3):207-18. PubMed ID: 15307119
[TBL] [Abstract][Full Text] [Related]
11. Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease.
Mroz MM; Maier LA; Strand M; Silviera L; Newman LS
Am J Ind Med; 2009 Oct; 52(10):762-73. PubMed ID: 19681064
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of a program to prevent beryllium disease.
Thomas CA; Deubner DC; Stanton ML; Kreiss K; Schuler CR
Am J Ind Med; 2013 Jul; 56(7):733-41. PubMed ID: 23450749
[TBL] [Abstract][Full Text] [Related]
13. Beryllium disease among construction trade workers at Department of Energy nuclear sites: A follow-up.
Cloeren M; Dement J; Gaitens J; Hines S; Diaz L; Tembunde Y; Cranford K; Shorter J; Mosier T; Ringen K;
Am J Ind Med; 2022 Sep; 65(9):708-720. PubMed ID: 35833586
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of beryllium sensitized workers from a single employer.
Duggal M; Deubner DC; Curtis AM; Cullen MR
BMC Public Health; 2010 Jan; 10():5. PubMed ID: 20047684
[TBL] [Abstract][Full Text] [Related]
15. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility.
Deubner D; Kelsh M; Shum M; Maier L; Kent M; Lau E
Appl Occup Environ Hyg; 2001 May; 16(5):579-92. PubMed ID: 11370937
[TBL] [Abstract][Full Text] [Related]
16. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers.
Schuler CR; Virji MA; Deubner DC; Stanton ML; Stefaniak AB; Day GA; Park JY; Kent MS; Sparks R; Kreiss K
Scand J Work Environ Health; 2012 May; 38(3):270-81. PubMed ID: 21877099
[TBL] [Abstract][Full Text] [Related]
17. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.
Kent MS; Robins TG; Madl AK
Appl Occup Environ Hyg; 2001 May; 16(5):539-58. PubMed ID: 11370934
[TBL] [Abstract][Full Text] [Related]
18. Illness absences among beryllium sensitized workers.
Watkins JP; Ellis ED; Girardi DJ; Cragle DL; Richter BS
Am J Public Health; 2014 Nov; 104(11):e165-9. PubMed ID: 25211750
[TBL] [Abstract][Full Text] [Related]
19. The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance.
Stange AW; Furman FJ; Hilmas DE
Am J Ind Med; 2004 Nov; 46(5):453-62. PubMed ID: 15490468
[TBL] [Abstract][Full Text] [Related]
20. Comments on the choice of exposure metrics as risk indicators.
Wambach PF
J Occup Environ Hyg; 2007 Oct; 4(10):D103-4; author reply D104-8. PubMed ID: 17763067
[No Abstract] [Full Text] [Related]
[Next] [New Search]
